Korea Joongang Daily
Korea JoongAng Daily

Celltrion megamerger to create $9 billion pharma giant

A merger of three listed Celltrion companies will be done by next year to create a pharmaceutical behemoth that logs around 12 trillion won ($8.9 billion) of yearly revenues by 2030, says its founder and chairman Seo Jung-jin.

2023-10-25

Celltrion brings Remsima SC biosimilar to the Netherlands

Celltrion Healthcare introduced Remsima SC in the Netherlands, the third European market where it has rolled out the biosimilar. Celltrion Group sales company announced Thursday that it began selling Remsima SC in the country on April 27.

2020-05-07